…
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Bioceres Crop Solutions Corp provides seeds, crop protection, biologicals and digital agriculture solutions to farmers, with a commercial focus in Latin America. Long-term growth may be supported by wider adoption of seed traits and biological inputs and by geographic expansion, which could diversify revenue and increase recurring sales.
Primary investment risks include regulatory and commercialization uncertainty for biotech traits, commodity and currency volatility in its markets, and execution and financing challenges during scaling.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
| Income before tax | -53.90M | 10.04M | 19.11M | 14.06M | 14.06M |
| Minority interest | 3.43M | -3.01M | -1.39M | -3.10M | -3.10M |
| Net income | -51.80M | 3.24M | 18.78M | -3.91M | -7.20M |
| Selling general administrative | 72.47M | 77.45M | 70.23M | 51.67M | 42.99M |
| Selling and marketing expenses | 15.88M | 16.82M | 16.71M | 6.50M | 16.03M |
| Gross profit | 130.20M | 181.59M | 180.25M | 126.44M | 126.44M |
| Reconciled depreciation | 22.18M | 21.30M | 19.39M | 19.39M | 19.39M |
| Ebit | -3.80M | 34.16M | 41.70M | 39.87M | 30.85M |
| Ebitda | 13.59M | 55.46M | 61.09M | 49.33M | 40.03M |
| Depreciation and amortization | 17.39M | 21.30M | 19.39M | 9.46M | 9.19M |
| Operating income | -3.70M | 44.82M | 54.18M | 39.87M | 39.87M |
| Other operating expenses | 337.00M | 420.01M | 365.13M | 287.29M | 288.13M |
| Interest expense | 50.10M | 26.87M | 21.23M | 14.95M | 14.95M |
| Tax provision | 1.27M | 3.78M | -1.07M | -1.00M | -1.00M |
| Net interest income | -33.71M | -26.87M | -23.79M | -35.30M | -35.30M |
| Income tax expense | 1.30M | 3.78M | -1.07M | 17.97M | 17.97M |
| Total revenue | 333.30M | 464.83M | 419.45M | 328.46M | 328.46M |
| Total operating expenses | 133.90M | 136.77M | 125.94M | 85.27M | 86.11M |
| Cost of revenue | 203.10M | 283.24M | 239.20M | 202.02M | 202.02M |
| Total other income expense net | -50.20M | -34.79M | -35.08M | -25.81M | -25.81M |
| Net income from continuing ops | -58.85M | 6.26M | 20.17M | 19.80M | 19.80M |
| Net income applicable to common shares | - | - | - | 18.78M | 18.78M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
| Total assets | 763.65M | 850.63M | 818.06M | 518.22M | 518.22M |
| Intangible assets | 181.17M | 174.80M | 173.78M | 76.70M | 76.70M |
| Other current assets | 5.83M | 10.24M | 11.17M | 4.91M | 4.91M |
| Total liab | 468.43M | 501.06M | 487.56M | 359.92M | 359.92M |
| Total stockholder equity | 262.81M | 314.01M | 298.85M | 127.36M | 127.61M |
| Other current liab | 9.51M | 13.28M | 11.98M | 19.65M | 10.80M |
| Common stock | 0.01M | 0.01M | 0.01M | 0.00M | 0.00M |
| Capital stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Retained earnings | -65.04M | -10.66M | -13.90M | -32.68M | -32.68M |
| Other liab | - | - | - | 42.94M | 42.94M |
| Good will | 112.16M | 112.34M | 112.16M | 36.07M | 36.07M |
| Other assets | - | - | - | 13.47M | 13.47M |
| Cash | 32.70M | 44.47M | 48.13M | 33.48M | 33.48M |
| Total current liabilities | 337.99M | 329.51M | 298.71M | 222.67M | 222.67M |
| Current deferred revenue | 4.28M | 3.92M | 24.88M | 5.90M | 5.90M |
| Net debt | 243.91M | 226.47M | 209.28M | 136.31M | 136.31M |
| Short term debt | 228.88M | 139.87M | 111.50M | 72.71M | 72.71M |
| Short long term debt | 222.00M | 136.75M | 107.64M | 108.90M | 108.90M |
| Short long term debt total | 276.61M | 270.95M | 257.41M | 169.79M | 169.79M |
| Other stockholder equity | 327.75M | 294.01M | 311.37M | 158.06M | 158.06M |
| Property plant equipment | - | - | - | 81.79M | 81.79M |
| Total current assets | 308.31M | 408.67M | 397.11M | 297.71M | 297.71M |
| Long term investments | 39.37M | 40.42M | 39.74M | 40.30M | 40.30M |
| Net tangible assets | - | - | - | 12.65M | 12.65M |
| Short term investments | 2.04M | 11.70M | 11.92M | 5.14M | 5.14M |
| Net receivables | 177.75M | 216.03M | 185.32M | 128.08M | 128.08M |
| Long term debt | 38.20M | 122.91M | 135.88M | 135.90M | 135.90M |
| Inventory | 89.99M | 126.22M | 140.57M | 126.10M | 126.10M |
| Accounts payable | 91.58M | 161.96M | 146.29M | 124.41M | 124.45M |
| Accumulated other comprehensive income | 0.09M | 29.09M | 1.12M | 1.98M | 1.98M |
| Non currrent assets other | 26.76M | 18.53M | 6.15M | 2.50M | 2.50M |
| Non current assets total | 455.33M | 441.96M | 420.94M | 220.52M | 220.52M |
| Capital lease obligations | 16.41M | 11.28M | 13.89M | 13.90M | 13.90M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | 2022-06-30 |
| Investments | -6.13M | -28.73M | -25.73M | -25.73M | -25.73M |
| Change to liabilities | - | - | - | 8.82M | 8.82M |
| Total cashflows from investing activities | -6.13M | - | - | -25.73M | -25.73M |
| Net borrowings | -27.57M | - | - | 59.22M | 59.22M |
| Total cash from financing activities | -50.71M | -10.06M | 32.95M | 14.82M | 14.82M |
| Change to operating activities | - | - | - | -4.46M | -4.46M |
| Net income | -58.85M | 6.26M | 20.17M | -3.91M | -3.91M |
| Change in cash | -11.78M | -3.66M | 14.65M | -2.57M | -2.57M |
| Begin period cash flow | 44.47M | 48.13M | 33.48M | 36.05M | 36.05M |
| End period cash flow | 32.70M | 44.47M | 48.13M | 33.48M | 33.48M |
| Total cash from operating activities | 49.91M | 41.72M | 2.59M | -17.52M | -17.52M |
| Depreciation | 22.18M | 21.30M | 19.39M | 9.19M | 9.19M |
| Other cashflows from investing activities | -8.97M | - | - | - | - |
| Dividends paid | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to inventory | 34.91M | 14.18M | -11.07M | -55.31M | -55.31M |
| Change to account receivables | 24.58M | -51.65M | -56.87M | -24.97M | -24.97M |
| Sale purchase of stock | -0.93M | -0.73M | -3.00M | -3.00M | -3.00M |
| Other cashflows from financing activities | -22.21M | -27.65M | -23.27M | 139.49M | -13.91M |
| Change to netincome | - | - | - | 48.22M | 48.22M |
| Capital expenditures | 14.61M | 22.78M | 22.56M | 9.00M | 9.00M |
| Change in working capital | 19.30M | -41.51M | -85.11M | -60.85M | -60.85M |
| Stock based compensation | 4.39M | 14.13M | 3.42M | 1.43M | 1.43M |
| Other non cash items | 61.61M | 37.76M | 45.78M | 18.65M | 18.65M |
| Free cash flow | 35.30M | 18.93M | -19.97M | -26.51M | -26.51M |
Sector: Basic Materials Industry: Agricultural Inputs
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BIOX Bioceres Crop Solutions Corp |
0.01 4.57% |
0.24 | - | 14.99 | 0.12 | 0.57 | 0.92 | 17.98 |
| CTA-PB E. I. du Pont de Nemours and Company |
-0.10 0.18% |
56.40 | - | - | 3.43 | - | - | - |
| CTVA Corteva Inc |
0.27 2.23% |
12.16 | 49.93 | 19.65 | 3.12 | 2.19 | 3.23 | 19.19 |
| CTA-PA E. I. du Pont de Nemours and Company |
-0.48 1.04% |
45.52 | - | - | 2.71 | - | - | - |
| NTR Nutrien Ltd |
1.25 1.74% |
72.72 | 15.94 | 14.90 | 1.38 | 1.42 | 1.72 | 7.72 |
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
Ocampo 210 bis, Rosario, Argentina, 2000
54 91 1347 24616
751
| Name | Title | Year Born |
|---|---|---|
| Jose A. Roque | Gen. Counsel | NA |
| Dr. Federico Trucco Ph.D. | Chairman & CEO | 1977 |
| Mr. Enrique López Lecube | CFO & Exec. Director | 1982 |
| Mr. Jorge Wagner | Chief Operating Officer | 1969 |
| Rodrigo Krause | Head of Investor Relations | NA |
| Mr. Ricardo Luis Yapur | Managing Director of Latam Unit & Chief Commercial Officer | 1958 |
| Mr. Matti Tiainen | Managing Director of North America & Europe | 1989 |
| Jose A. Roque | General Counsel | NA |
| Alex Garcia | Managing Director of Seeds | NA |
| Dr. Federico Trucco Ph.D. | Executive Chairman & CEO | 1977 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.